Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
ASKA Pharmaceutical Holdings Co Ltd
4886ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan. Address: 5-1, Shibaura 2-Chome, Tokyo, Japan, 108-8532
Analytics
Zielpreis von Wall Street
380 683.76 JPYKGV
10.0598Dividendenrendite
2.31 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 4886
Dividenden-Analyse 4886
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
2 JahreAusschüttungsquote 5-Jahres-Durchschnitt
12 %Verlauf der Dividende 4886
Bewertung der Aktie 4886
Finanzen 4886
Ergebnisse | 2019 | Dynamik |